Wyoming, OH, United States of America

Gilles Yves Genain


Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 1998-1999

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Gilles Yves Genain

Introduction

Gilles Yves Genain, based in Wyoming, Ohio, is a notable inventor with a focus on pharmaceutical innovations. His work has led to three patents, contributing significantly to the field of medicine, particularly in treating congestive heart failure.

Latest Patents

Genain's latest patents include "Urethane-containing aminosteroid compounds," which encompasses aminosteroids with a specific chemical formula. This invention includes pharmaceutical compositions and their applications in the treatment of congestive heart failure. Another significant patent is for "Deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds." This invention details a method to create specific compounds through a series of precise chemical reactions, showcasing Genain's innovation in the pharmaceutical sector.

Career Highlights

Throughout his career, Genain has been associated with prominent organizations, including Procter & Gamble and Procter & Gamble Pharmaceuticals, Inc. His tenure at these companies allowed him to develop and refine his inventive strategies and contribute to advancements in medicine.

Collaborations

Genain has worked alongside talented professionals such as Song Liu and David Edward Portlock. These collaborations have played a crucial role in fostering innovation and enhancing his contributions to pharmaceutical research.

Conclusion

Gilles Yves Genain exemplifies the spirit of innovation within the pharmaceutical industry. His patents reflect a commitment to improving health outcomes, particularly for patients with congestive heart failure. His career and collaborations continue to inspire advancements in medical science, highlighting the importance of inventive minds in addressing healthcare challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…